354994-01-7 Usage
Uses
Used in Pharmaceutical Industry:
4-[N'-(4,6-DIMETHYL-PYRIMIDIN-2-YL)-GUANIDINO]-BENZOIC ACID is used as a potential therapeutic agent for its anti-inflammatory and anti-cancer properties. Its ability to inhibit the proliferation of cancer cells and reduce inflammation makes it a promising candidate for the development of new drugs to treat various types of cancer and inflammatory conditions.
Used in Oncology Research:
In the field of oncology, 4-[N'-(4,6-DIMETHYL-PYRIMIDIN-2-YL)-GUANIDINO]-BENZOIC ACID is used as a potential anti-cancer agent. Its potential to inhibit the proliferation of cancer cells and its anti-inflammatory properties make it a valuable compound for further research and development of novel cancer treatments.
Used in Inflammation Research:
4-[N'-(4,6-DIMETHYL-PYRIMIDIN-2-YL)-GUANIDINO]-BENZOIC ACID is used as a potential anti-inflammatory agent in the field of inflammation research. Its ability to reduce inflammation makes it a promising candidate for the development of new treatments for various inflammatory conditions.
Used in Drug Development:
4-[N'-(4,6-DIMETHYL-PYRIMIDIN-2-YL)-GUANIDINO]-BENZOIC ACID is used as a lead compound in drug development. Its unique chemical structure and properties, including a guanidine group, a pyrimidine ring, and a benzoic acid moiety, make it a valuable starting point for the design and synthesis of new therapeutic agents with potential applications in oncology and inflammation treatment.
Check Digit Verification of cas no
The CAS Registry Mumber 354994-01-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,4,9,9 and 4 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 354994-01:
(8*3)+(7*5)+(6*4)+(5*9)+(4*9)+(3*4)+(2*0)+(1*1)=177
177 % 10 = 7
So 354994-01-7 is a valid CAS Registry Number.
InChI:InChI=1/C14H15N5O2/c1-8-7-9(2)17-14(16-8)19-13(15)18-11-5-3-10(4-6-11)12(20)21/h3-7H,1-2H3,(H,20,21)(H3,15,16,17,18,19)
354994-01-7Relevant academic research and scientific papers
HETEROARYL GUANIDINES ; INHIBITORS OF VIRAL REPLICATION
-
Page/Page column 42; 47, (2008/06/13)
Compounds of Formula (1), and pharmaceutically acceptable forms thereof, are provided wherein the variables X, Y, Z, Al, R2, R3, R4, R5 and R6 are defined herein. Certain compounds of Formula 1 described herein which possess potent antiviral activity. Certain compounds of Formula (1) that are potent and/ or selective inhibitors of Hepatitis C virus replication. Pharmaceutical compositions containing one or more compounds of Formula (1), or a salt, solvate, or acylated prodrug of such compounds, and one or more pharmaceutically acceptable carriers, excipients, or diluents are also provided. Methods of treating patients suffering from certain infectious diseases by administering to such patients an amount of a compound of Formula (1) effective to reduce signs or symptoms of the disease or disorder are disclosed. These infectious diseases include viral infections, particularly HCV infections. Methods of treating human patients suffering from an infectious disease, but also encompasses methods of treating other animals, including livestock and domesticated companion animals, suffering from an infectious disease. Methods of treatment include administering a compound of Formula (1) as a single active agent or administering a compound of Formula (1) in combination with on or more other therapeutic agent.
